Part of Phaidon International
Part of Phaidon International
Showing 33 results
Sort by:
Senior Director, Head of Clinical Pharmacology - OncologySan Francisco, California (Hybrid)Salary: 290-330,000 base + 30% bonus + RSUs + additional benefitsAbout the OpportunityOur client, a clinical-stage biotechnology company advancing innovative therapies across oncology and immunology-focused programs, is seeking an accomplished Senior Director...
Oncology Account ManagerTerritory: Greater San Diego AreaCompany: Midsized Pharmaceutical Company Role OverviewA midsized pharmaceutical company is seeking a dedicated Oncology Account Manager to cover their San Diego territory. This role is pivotal in driving sales and establishing strong relationships with key thought leaders and prescribers with...
EPM Scientific are working with a leading firm who are seeking a Executive Director to join their team. Reporting into the SVP of Biometrics, this is the senior-most Clinical Data Management leader within the organization. You'll own the CDM strategy, lead and develop the team, and serve as a key partner to executive leadership as the company adva...
Take the first step toward your next opportunity - submit your CV and get started today.
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...